### Regulatory Status and Availability **AOD-9604:** - Never received FDA approval for any indication - Classified by the FDA as a **Category 2 bulk drug substance** not eligible for compounding under Section 503B - Removed from many international peptide supplier platforms (including Alibaba and related marketplaces) - Legal status varies by country
Final Verdict on AOD-9604 Safety While AOD-9604 appears to be a safer alternative to traditional hGH therapy, its long-term effects remain unclear
They are not intended to represent clinical evidence in humans, and 5-Amino-1MQ has not been approved by the FDA, EMA, or any other regulatory authority for any indication
In these cases, says Barrient, B12 supplementationeither orally or with injectionsmay help improve symptoms like fatigue, mood changes, weakness, and memory loss
Researchers reported that growth hormone may increase lean body mass, while AOD 9604 did not appear to show the same trend